BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37304289)

  • 1. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
    Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
    Qiao T; Chen L; Jiang L; Wei H; Chen X; Li X; Chen Y; Xu Y
    Front Immunol; 2022; 13():986853. PubMed ID: 36211373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Limbic Encephalitis With New-Onset Panic Attacks.
    Coleman B; Sawhney K; LaPenna P
    Cureus; 2024 Apr; 16(4):e58406. PubMed ID: 38756253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
    Li Y; Jia Y
    Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
    Yang J; Sun Q; Yang G
    Front Neurol; 2020; 11():61. PubMed ID: 32153488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report/Case Series: Rare case of anti-LGI1 limbic encephalitis with rapidly progressive dementia, psychiatric symptoms, and frequently seizures: A case report.
    Wu H; Mei F; Liu L; Zhang L; Hao H; Zhang S
    Medicine (Baltimore); 2021 Jul; 100(29):e26654. PubMed ID: 34398024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faciobrachial motor seizures: A more apt description?
    Muthusamy S; Foroush NC; Seneviratne U
    Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
    Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.
    Teng Y; Li T; Yang Z; Su M; Ni J; Wei M; Shi J; Tian J
    Front Neurol; 2021; 12():791014. PubMed ID: 35095736
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychiatric Manifestation of Anti-LGI1 Encephalitis.
    Endres D; Prüss H; Dressing A; Schneider J; Feige B; Schweizer T; Venhoff N; Nickel K; Meixensberger S; Matysik M; Maier SJ; Domschke K; Urbach H; Meyer PT; Tebartz van Elst L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
    Zlotnik Y; Gadoth A; Abu-Salameh I; Horev A; Novoa R; Ifergane G
    Front Immunol; 2021; 12():813487. PubMed ID: 35069602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.